Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 326

1.

Consequences of chronic kidney disease in chronic obstructive pulmonary disease.

Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R; German COSYCONET consortium.

Respir Res. 2019 Jul 12;20(1):151. doi: 10.1186/s12931-019-1107-x.

PMID:
31299972
Free Article
2.

Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study.

Schunk SJ, Zarbock A, Meersch M, Küllmar M, Kellum JA, Schmit D, Wagner M, Triem S, Wagenpfeil S, Gröne HJ, Schäfers HJ, Fliser D, Speer T, Zewinger S.

Lancet. 2019 Jun 12. pii: S0140-6736(19)30769-X. doi: 10.1016/S0140-6736(19)30769-X. [Epub ahead of print]

PMID:
31202596
3.

Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.

Massy ZA, Caskey FJ, Finne P, Harambat J, Jager KJ, Nagler E, Stengel B, Sever MS, Vanholder R, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Soler MJ, Rychlík I, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Jun 14. pii: gfz089. doi: 10.1093/ndt/gfz089. [Epub ahead of print]

PMID:
31197325
4.

Proprotein convertase subtilisin/kexin type 9 in kidney disease.

Schmit D, Fliser D, Speer T.

Nephrol Dial Transplant. 2019 Jun 13. pii: gfz122. doi: 10.1093/ndt/gfz122. [Epub ahead of print]

PMID:
31190079
5.

Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care.

Pecoits-Filho R, Fliser D, Tu C, Zee J, Bieber B, Wong MMY, Port F, Combe C, Lopes AA, Reichel H, Narita I, Stengel B, Robinson BM, Massy Z; CKDopps Investigators.

J Clin Hypertens (Greenwich). 2019 Jun 6. doi: 10.1111/jch.13563. [Epub ahead of print]

6.

Mild cognitive impairment and kidney disease: clinical aspects.

Viggiano D, Wagner CA, Blankestijn PJ, Bruchfeld A, Fliser D, Fouque D, Frische S, Gesualdo L, Gutiérrez E, Goumenos D, Hoorn EJ, Eckardt KU, Knauß S, König M, Malyszko J, Massy Z, Nitsch D, Pesce F, Rychlík I, Soler MJ, Spasovski G, Stevens KI, Trepiccione F, Wanner C, Wiecek A, Zoccali C, Unwin R, Capasso G.

Nephrol Dial Transplant. 2019 Apr 9. pii: gfz051. doi: 10.1093/ndt/gfz051. [Epub ahead of print] No abstract available.

PMID:
31071220
7.

Erratum to Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials

Zoccali C, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Massy Z, Rychlık I, Soler MJ, Stevens K, Spasovski G, Wanner C.

Nephrol Dial Transplant. 2019 Apr 12. pii: gfz070. doi: 10.1093/ndt/gfz070. [Epub ahead of print] No abstract available.

PMID:
30977814
8.

Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study.

Weingärtner O, Lütjohann D, Meyer S, Fuhrmann A, Cremers B, Seiler-Mußler S, Schött HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada A, Laufs U, Schulze PC, Scheller B, Fliser D, Böhm M, Sijbrands E, Heine GH.

Clin Res Cardiol. 2019 Apr 4. doi: 10.1007/s00392-019-01474-2. [Epub ahead of print]

PMID:
30949753
9.

Children of a lesser god: exclusion of chronic kidney disease patients from clinical trials.

Zoccali C, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Massy Z, Rychlık I, Jose Soler M, Stevens K, Spasovski G, Wanner C.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1112-1114. doi: 10.1093/ndt/gfz023.

PMID:
30815678
10.

Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.

Emrich IE, Brandenburg V, Sellier AB, Schauerte J, Wiedenroth J, Untersteller K, Lennartz CS, Seiler-Mussler S, Wagenpfeil S, Fliser D, Heine GH.

Am J Nephrol. 2019;49(3):203-211. doi: 10.1159/000497125. Epub 2019 Feb 26.

PMID:
30808827
11.

Erratum.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2019 Jan 21. doi: 10.1093/ndt/gfy408. [Epub ahead of print] No abstract available.

PMID:
30668741
12.

Lancet Countdown paper: what does it mean for nephrology?

Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Massy Z, Rychlík I, Soler MJ, Spasovski G, Stevens K, Wanner C, Zoccali C.

Nephrol Dial Transplant. 2019 Jan 1;34(1):4-6. doi: 10.1093/ndt/gfy369. No abstract available.

PMID:
30496519
13.

Plasma levels of the oxyphytosterol 7α-hydroxycampesterol are associated with cardiovascular events.

Fuhrmann A, Weingärtner O, Meyer S, Cremers B, Seiler-Mußler S, Schött HF, Kerksiek A, Friedrichs S, Ulbricht U, Zawada AM, Laufs U, Scheller B, Fliser D, Schulze PC, Böhm M, Heine GH, Lütjohann D.

Atherosclerosis. 2018 Dec;279:17-22. doi: 10.1016/j.atherosclerosis.2018.10.010. Epub 2018 Oct 17.

PMID:
30366187
14.

Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.

Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, Schunk SJ, Petrakis I, Schmit D, Wagenpfeil S, Heine GH, Mayer G, Floege J, Fliser D, Gröne HJ, Speer T.

J Am Soc Nephrol. 2018 Nov;29(11):2722-2733. doi: 10.1681/ASN.2018040405. Epub 2018 Oct 2.

PMID:
30279273
15.

The Circular RNA ciRs-126 Predicts Survival in Critically Ill Patients With Acute Kidney Injury.

Kölling M, Seeger H, Haddad G, Kistler A, Nowak A, Faulhaber-Walter R, Kielstein J, Haller H, Fliser D, Mueller T, Wüthrich RP, Lorenzen JM.

Kidney Int Rep. 2018 Jun 2;3(5):1144-1152. doi: 10.1016/j.ekir.2018.05.012. eCollection 2018 Sep.

16.

Plasma FGF23 does not rise during physical exercise as a physiological model of sympathetic activation.

Emrich IE, Baier M, Zawada AM, Meyer T, Fliser D, Scharhag J, Heine GH.

Clin Res Cardiol. 2019 Mar;108(3):341-343. doi: 10.1007/s00392-018-1347-7. Epub 2018 Aug 8. No abstract available.

PMID:
30091082
17.

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council.

Zoccali C, Arici M, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G.

Clin Kidney J. 2018 Aug;11(4):437-442. doi: 10.1093/ckj/sfy064. Epub 2018 Jul 31.

18.

L-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis.

Martens-Lobenhoffer J, Emrich IE, Zawada AM, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.

Amino Acids. 2018 Oct;50(10):1347-1356. doi: 10.1007/s00726-018-2610-y. Epub 2018 Jul 7.

PMID:
29982953
19.

ERA-EDTA invests in transformation to greener health care.

Blankestijn PJ, Arici M, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G, Zoccali C.

Nephrol Dial Transplant. 2018 Jun 1;33(6):901-903. doi: 10.1093/ndt/gfy092. No abstract available.

PMID:
29800317
20.

The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA Council.

Zoccali C, Arici M, Blankestijn PJ, Bruchfeld A, Capasso G, Fliser D, Fouque D, Goumenos D, Ketteler M, Malyszko J, Massy Z, Rychlík I, Spasovski G.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1077-1082. doi: 10.1093/ndt/gfy173.

PMID:
29796635
21.

HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.

Untersteller K, Meissl S, Trieb M, Emrich IE, Zawada AM, Holzer M, Knuplez E, Fliser D, Heine GH, Marsche G.

J Lipid Res. 2018 Jul;59(7):1256-1265. doi: 10.1194/jlr.P085076. Epub 2018 May 22.

22.

Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Marx N, Noels H, Jankowski J, Floege J, Fliser D, Böhm M.

Clin Res Cardiol. 2018 Aug;107(Suppl 2):120-126. doi: 10.1007/s00392-018-1260-0. Epub 2018 May 4. Review.

PMID:
29728829
23.

Do plasma neprilysin activity and plasma neprilysin concentration predict cardiac events in chronic kidney disease patients?

Emrich IE, Vodovar N, Feuer L, Untersteller K, Nougue H, Seiler-Mussler S, Fliser D, Launay JM, Heine GH.

Nephrol Dial Transplant. 2019 Jan 1;34(1):100-108. doi: 10.1093/ndt/gfy066.

PMID:
29635392
24.

The new SFB/TRR219 Research Centre.

Noels H, Boor P, Goettsch C, Hohl M, Jahnen-Dechent W, Jankowski V, Kindermann I, Kramann R, Lehrke M, Linz D, Maack C, Niemeyer B, Roma LP, Schuett K, Speer T, Wagenpfeil S, Werner C, Zewinger S, Böhm M, Marx N, Floege J, Fliser D, Jankowski J.

Eur Heart J. 2018 Mar 21;39(12):975-977. doi: 10.1093/eurheartj/ehy083. No abstract available.

PMID:
29579229
25.

Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.

Seiler-Mussler S, Limbach AS, Emrich IE, Pickering JW, Roth HJ, Fliser D, Heine GH.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):569-576. doi: 10.2215/CJN.06620617. Epub 2018 Mar 5.

26.

Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury.

Kölling M, Genschel C, Kaucsar T, Hübner A, Rong S, Schmitt R, Sörensen-Zender I, Haddad G, Kistler A, Seeger H, Kielstein JT, Fliser D, Haller H, Wüthrich R, Zörnig M, Thum T, Lorenzen J.

Sci Rep. 2018 Feb 21;8(1):3438. doi: 10.1038/s41598-018-21720-3.

27.

Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.

Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A.

Crit Care. 2017 Nov 29;21(1):294. doi: 10.1186/s13054-017-1870-3.

28.

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2018 Apr 1;33(4):653-660. doi: 10.1093/ndt/gfx197.

PMID:
29106648
29.

Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.

Emrich IE, Zawada AM, Martens-Lobenhoffer J, Fliser D, Wagenpfeil S, Heine GH, Bode-Böger SM.

Clin Res Cardiol. 2018 Mar;107(3):201-213. doi: 10.1007/s00392-017-1172-4. Epub 2017 Nov 3.

PMID:
29101459
30.

Reprint of: MicroRNA profiling of human intermediate monocytes.

Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.

Immunobiology. 2017 Jun;222(6):831-840. doi: 10.1016/j.imbio.2017.05.003. Epub 2017 May 31.

PMID:
28578934
31.

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygård O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mündlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagström E, Wallentin L, Åkerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS; GENIUS-CHD consortium, Krämer BK, Scharnagl H, Fliser D, März W, Speer T.

Lancet Diabetes Endocrinol. 2017 Jul;5(7):534-543. doi: 10.1016/S2213-8587(17)30096-7. Epub 2017 May 26.

32.

The systemic nature of CKD.

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA).

Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24. Review.

PMID:
28435157
33.

Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation.

Fischer M, Leyking S, Schäfer M, Elsäßer J, Janssen M, Mihm J, van Bentum K, Fliser D, Sester M, Sester U.

Eur J Immunol. 2017 Jul;47(7):1220-1231. doi: 10.1002/eji.201646826. Epub 2017 May 17.

34.

[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Schlieper G, Schwenger V, Remppis A, Keller T, Dechend R, Massberg S, Baldus S, Weinreich T, Hetzel G, Floege J, Mahfoud F, Fliser D.

Internist (Berl). 2017 May;58(5):512-521. doi: 10.1007/s00108-017-0220-5. Review. German.

PMID:
28396914
35.

Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.

Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Böger RH, Laufs U, von Eckardstein A, Landmesser U, Lüscher TF, Fliser D, März W, Meinitzer A, Speer T.

Eur Heart J. 2017 May 21;38(20):1597-1607. doi: 10.1093/eurheartj/ehx118.

PMID:
28379378
36.

Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.

Fliser D, Dellanna F, Koch M, Wiggenhauser A; PRIMAVERA study group.

Nephrol Dial Transplant. 2017 Feb 1;32(2):279-287. doi: 10.1093/ndt/gfw418.

PMID:
28186540
37.

HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.

Bauer L, Kern S, Rogacev KS, Emrich IE, Zawada A, Fliser D, Heinemann A, Heine GH, Marsche G.

J Am Coll Cardiol. 2017 Jan 17;69(2):246-247. doi: 10.1016/j.jacc.2016.10.054. No abstract available.

38.

MicroRNA profiling of human intermediate monocytes.

Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.

Immunobiology. 2017 Mar;222(3):587-596. doi: 10.1016/j.imbio.2016.11.006. Epub 2016 Nov 13.

PMID:
27876379
39.

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy.

Humalda JK, Seiler-Muler S, Kwakernaak AJ, Vervloet MG, Navis G, Fliser D, Heine GH, de Borst MH.

Medicine (Baltimore). 2016 Nov;95(46):e5003.

40.

Impact of individual intravenous iron preparations on the differentiation of monocytes towards macrophages and dendritic cells.

Fell LH, Seiler-Mußler S, Sellier AB, Rotter B, Winter P, Sester M, Fliser D, Heine GH, Zawada AM.

Nephrol Dial Transplant. 2016 Nov;31(11):1835-1845. Epub 2016 Mar 24.

41.

Innate immunity in CKD-associated vascular diseases.

Zewinger S, Schumann T, Fliser D, Speer T.

Nephrol Dial Transplant. 2016 Nov;31(11):1813-1821. Epub 2015 Oct 9. Review.

PMID:
26454223
42.

Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.

Federico G, Meister M, Mathow D, Heine GH, Moldenhauer G, Popovic ZV, Nordström V, Kopp-Schneider A, Hielscher T, Nelson PJ, Schaefer F, Porubsky S, Fliser D, Arnold B, Gröne HJ.

JCI Insight. 2016 Jan 21;1(1):e84916. doi: 10.1172/jci.insight.84916.

43.

Efficacy of a remote web-based lung ultrasound training for nephrologists and cardiologists: a LUST trial sub-project.

Gargani L, Sicari R, Raciti M, Serasini L, Passera M, Torino C, Letachowicz K, Ekart R, Fliser D, Covic A, Balafa O, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Shavit L, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Kraemer TD, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Onofriescu M, Zarzoulas F, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C.

Nephrol Dial Transplant. 2016 Dec;31(12):1982-1988. Epub 2016 Sep 26.

PMID:
27672089
44.

The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study.

Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Caiazza A, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Gueler F, Hannedouche T, Panichi V, Wiecek A, Pontoriero G, Sarafidis P, Klinger M, Hojs R, Seiler-Mussler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2005-2011. Epub 2016 Sep 22.

45.

NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.

Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, Rossignol P, Heine GH.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1978-1988. Epub 2016 Aug 11.

46.

Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection.

Mihm J, Leyking S, Dirks J, Smola S, Fliser D, Sester U, Sester M, Wilkens H, Rissland J.

J Clin Virol. 2016 Sep;82:5-8. doi: 10.1016/j.jcv.2016.06.013. Epub 2016 Jun 22.

PMID:
27389910
47.

Best Albuminuria Measurement to Predict Cardiovascular and Renal Events.

Bauer L, Emrich IE, Pickering JW, Untersteller K, Sandermann F, Rogacev KS, Seiler-Mussler S, Fliser D, Heine GH.

Am J Nephrol. 2016;43(5):383-8. doi: 10.1159/000446483. Epub 2016 May 18.

48.

Hypertension in Chronic Kidney Disease Part 1: Out-of-Office Blood Pressure Monitoring: Methods, Thresholds, and Patterns.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C; European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis Transplantation Association (ERA-EDTA).

Hypertension. 2016 Jun;67(6):1093-101. doi: 10.1161/HYPERTENSIONAHA.115.06895. Epub 2016 May 2. Review. No abstract available.

PMID:
27141058
49.

Hypertension in Chronic Kidney Disease Part 2: Role of Ambulatory and Home Blood Pressure Monitoring for Assessing Alterations in Blood Pressure Variability and Blood Pressure Profiles.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW, Fliser D, Heine GH, Jager KJ, Gargani L, Kanbay M, Mallamaci F, Massy Z, Ortiz A, Picano E, Rossignol P, Sarafidis P, Sicari R, Vanholder R, Wiecek A, London G, Zoccali C; European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis Transplantation Association (ERA-EDTA).

Hypertension. 2016 Jun;67(6):1102-10. doi: 10.1161/HYPERTENSIONAHA.115.06896. Epub 2016 May 2. Review. No abstract available.

PMID:
27141057
50.

The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.

Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, Pecoits-Filho R, Lopes AA, Yamagata K, Wada T, Wong MM, Speyer E, Port FK, Pisoni RL, Robinson BM.

Am J Kidney Dis. 2016 Sep;68(3):402-13. doi: 10.1053/j.ajkd.2016.03.414. Epub 2016 Apr 22.

PMID:
27113505

Supplemental Content

Loading ...
Support Center